AU1440088A - Dopamine receptor agonists in treating brain diseases - Google Patents
Dopamine receptor agonists in treating brain diseasesInfo
- Publication number
- AU1440088A AU1440088A AU14400/88A AU1440088A AU1440088A AU 1440088 A AU1440088 A AU 1440088A AU 14400/88 A AU14400/88 A AU 14400/88A AU 1440088 A AU1440088 A AU 1440088A AU 1440088 A AU1440088 A AU 1440088A
- Authority
- AU
- Australia
- Prior art keywords
- receptor agonists
- dopamine receptor
- brain diseases
- treating brain
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8708626 | 1987-04-10 | ||
GB878708626A GB8708626D0 (en) | 1987-04-10 | 1987-04-10 | Indolophenanthridines |
GB8708898 | 1987-04-14 | ||
GB878708898A GB8708898D0 (en) | 1987-04-14 | 1987-04-14 | Indolophenanthridines |
GB878710062A GB8710062D0 (en) | 1987-04-28 | 1987-04-28 | Indolophenanthridines |
GB8710062 | 1987-04-28 | ||
GB878720366A GB8720366D0 (en) | 1987-08-28 | 1987-08-28 | Dopamine d1 receptor agonists |
GB8720366 | 1987-08-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1440088A true AU1440088A (en) | 1988-10-13 |
Family
ID=27449909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU14400/88A Abandoned AU1440088A (en) | 1987-04-10 | 1988-04-08 | Dopamine receptor agonists in treating brain diseases |
Country Status (11)
Country | Link |
---|---|
US (1) | US4855306A ( ) |
JP (1) | JPS63258819A ( ) |
KR (1) | KR880012227A ( ) |
AU (1) | AU1440088A ( ) |
DE (1) | DE3811274A1 ( ) |
DK (1) | DK193588A ( ) |
FR (1) | FR2613623A1 ( ) |
GB (1) | GB2205495A ( ) |
IT (1) | IT1219906B ( ) |
NL (1) | NL8800823A ( ) |
SE (1) | SE8801275A0 ( ) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001514663A (ja) * | 1997-03-12 | 2001-09-11 | エスモンド,ロバート ダブリュー. | アルツハイマー病を処置または予防するための方法 |
US20040058873A1 (en) * | 1998-03-12 | 2004-03-25 | Esmond Robert W. | Method for treating or preventing Alzheimer's disease |
US6362371B1 (en) * | 1998-06-08 | 2002-03-26 | Advanced Medicine, Inc. | β2- adrenergic receptor agonists |
DE10148233A1 (de) * | 2001-09-28 | 2003-04-10 | Boehringer Ingelheim Pharma | Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme |
US20050215552A1 (en) * | 2002-05-17 | 2005-09-29 | Gadde Kishore M | Method for treating obesity |
JP4545584B2 (ja) * | 2002-05-17 | 2010-09-15 | デューク ユニバーシティ | 肥満を治療するための方法 |
DE10312809A1 (de) * | 2003-03-21 | 2004-09-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pramipexol zur Reduzierung übermäßiger Nahrungsaufnahme bei Kindern |
US20040266794A1 (en) * | 2003-03-21 | 2004-12-30 | Boehringer Ingelheim International Gmbh | Pramipexole for the reduction of excessive food intake for children |
PT2316456T (pt) * | 2003-04-29 | 2017-09-05 | Orexigen Therapeutics Inc | Composições para afetar a perda de peso compreendendo naltrexona e bupropion |
WO2004103262A2 (en) * | 2003-05-22 | 2004-12-02 | Yeda Research And Development Co. Ltd. | Dopamine and agonists and antagonists thereof for modulation of suppressive activity of cd4+cd25+ regulatory t cells |
BRPI0506829A (pt) * | 2004-01-13 | 2007-05-29 | Univ Duke | composições de anticonvulsivo e droga antipsicótica e métodos para sua utilização para afetar perda de peso |
US7713959B2 (en) * | 2004-01-13 | 2010-05-11 | Duke University | Compositions of an anticonvulsant and mirtazapine to prevent weight gain |
CA2565154A1 (en) * | 2004-05-03 | 2005-11-24 | Duke University | Compositions for affecting weight loss |
US20080306019A1 (en) * | 2005-05-03 | 2008-12-11 | Booze Rosemarie M | Dopamine Receptor Agonists in the Treatment and Prevention of Hiv-Induced Dementia |
DK2135603T3 (da) | 2005-11-22 | 2013-03-25 | Orexigen Therapeutics Inc | Sammensætninger og fremgangsmåder til øgning af insulinsensitivitet |
US8916195B2 (en) | 2006-06-05 | 2014-12-23 | Orexigen Therapeutics, Inc. | Sustained release formulation of naltrexone |
AU2007319472B2 (en) | 2006-11-09 | 2013-01-17 | Nalpropion Pharmaceuticals Llc | Methods Of Administering Weight Loss Medications |
CN101588795A (zh) | 2006-11-09 | 2009-11-25 | 奥雷西根治疗公司 | 包含中间快速溶解层的分层药物制剂 |
US20110144145A1 (en) | 2008-05-30 | 2011-06-16 | Orexigen Therapeutics, Inc. | Methods for treating visceral fat conditions |
CA2750903C (en) * | 2009-08-27 | 2015-08-11 | Daikin Industries, Ltd. | Processing additive, molding composition, masterbatch of processing additive and molding article |
AU2011203867B2 (en) | 2010-01-11 | 2015-12-03 | Nalpropion Pharmaceuticals Llc | Methods of providing weight loss therapy in patients with major depression |
EP2858640B1 (en) | 2012-06-06 | 2020-03-25 | Nalpropion Pharmaceuticals LLC | Composition for use in a method of treating overweight and obesity in patients with high cardiovascular risk |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3402392A1 (de) * | 1984-01-25 | 1985-08-01 | Sandoz-Patent-GmbH, 7850 Lörrach | Neue ergolinderivate, deren herstellung und deren verwendung |
-
1988
- 1988-03-31 NL NL8800823A patent/NL8800823A/nl not_active Application Discontinuation
- 1988-04-01 FR FR8804499A patent/FR2613623A1/fr not_active Withdrawn
- 1988-04-02 DE DE3811274A patent/DE3811274A1/de not_active Withdrawn
- 1988-04-05 IT IT47814/88A patent/IT1219906B/it active
- 1988-04-07 GB GB08808125A patent/GB2205495A/en active Pending
- 1988-04-07 US US07/178,668 patent/US4855306A/en not_active Expired - Fee Related
- 1988-04-08 AU AU14400/88A patent/AU1440088A/en not_active Abandoned
- 1988-04-08 SE SE8801275A patent/SE8801275A0/sv not_active Application Discontinuation
- 1988-04-08 DK DK193588A patent/DK193588A/da not_active Application Discontinuation
- 1988-04-09 KR KR1019880004023A patent/KR880012227A/ko not_active Application Discontinuation
- 1988-04-09 JP JP63088033A patent/JPS63258819A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
SE8801275L (sv) | 1988-10-19 |
US4855306A (en) | 1989-08-08 |
KR880012227A (ko) | 1988-11-26 |
JPS63258819A (ja) | 1988-10-26 |
NL8800823A (nl) | 1988-11-01 |
FR2613623A1 (fr) | 1988-10-14 |
GB2205495A (en) | 1988-12-14 |
DK193588A (da) | 1988-10-11 |
IT8847814A0 (it) | 1988-04-05 |
GB8808125D0 (en) | 1988-05-11 |
DE3811274A1 (de) | 1988-10-27 |
SE8801275D0 (sv) | 1988-04-08 |
IT1219906B (it) | 1990-05-24 |
DK193588D0 (da) | 1988-04-08 |
SE8801275A0 (sv) | 1988-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1440088A (en) | Dopamine receptor agonists in treating brain diseases | |
AU1374288A (en) | Skin substitute | |
HK1000603A1 (en) | Specific hydrogenated block copolymer composition and process for producing the same | |
EP0298386A3 (en) | Polymer hydrogenation process | |
EP0799617A3 (en) | Therapeutic agent for neurological diseases | |
AU1717888A (en) | Therapeutic helmets | |
GB8700658D0 (en) | Formulation process | |
AU2297388A (en) | Therapeutic agents | |
HUT46705A (en) | Process for producing christalline human proinsuline | |
AU2787889A (en) | Test for johne's disease | |
GB2226499B (en) | "pin setting means for use with bowling apparatus " | |
GB2200526B (en) | Harvesting apparatus | |
DK164988A (da) | Fremgangsmaade til fremstilling af chromanderivater | |
AU613355B2 (en) | Method for treating skin diseases | |
GB8724337D0 (en) | Apparatus for fishing | |
EP0310326A3 (en) | Expanding-contracting hydrogel composite and process for preparation thereof | |
EP0417789A3 (en) | Animal fiber for use as wadding | |
EP0464206A4 (en) | Drug for improving brain function | |
AU2297088A (en) | Improved ovulation treatment | |
AU2207188A (en) | Device for treatment of gum disease | |
EP0295531A3 (en) | Hydrogenation process | |
AU2193188A (en) | Improved distribution apparatus | |
AU2377288A (en) | Livestock treatment | |
GB8720366D0 (en) | Dopamine d1 receptor agonists | |
IL84734A0 (en) | Device for eye treatment |